If you are still having problems viewing this message, please click here for additional help.

Oncogene

Advertisement
Accurately predict Cas9 and sgRNA binding in your CRISPR experiments

Diagenode's iDeal ChIP-seq Kit for Transcription Factors:

  • Latest method of choice to verify sgRNA specificity
  • Uses robust ChIP method followed by qPCR to verify enrichment of dCas9 at expected target
  • Sequencing analysis of the immunoprecipitated DNA shows off-target effects genome-wide
Learn more and read the new application note.

TABLE OF CONTENTS

Volume 37, Issue 24

In this issue
Review Article
Article
Also new
AOP

Review Article

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

Matthew Dankner, April A. N. Rose, Shivshankari Rajkumar, Peter M. Siegel & Ian R. Watson

Oncogene 2018 37 :3183 - 3199; March 15, 2018; 10.1038/s41388-018-0171-x

Abstract | Full Text

The multiple paths towards MET receptor addiction in cancer

Leslie Duplaquet, Zoulika Kherrouche, Simon Baldacci, Philippe Jamme, Alexis B. Cortot et al.

Oncogene 2018 37 :3200 - 3215; March 19, 2018; 10.1038/s41388-018-0185-4

Abstract | Full Text

Article

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Vikash Reebye, Kai-Wen Huang, Vivian Lin, Sheba Jarvis, Pedro Cutilas et al.

Oncogene 2018 37 :3216 - 3228; March 07, 2018; 10.1038/s41388-018-0126-2

Abstract | Full Text

Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice

Jingxiao Wang, Mingjie Dong, Zhong Xu, Xinhua Song, Shanshan Zhang et al.

Oncogene 2018 37 :3229 - 3242; March 16, 2018; 10.1038/s41388-018-0188-1

Abstract | Full Text

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer

S. Wang, Z. Zou, X. Luo, Y. Mi, H. Chang et al.

Oncogene 2018 37 :3243 - 3259; March 16, 2018; 10.1038/s41388-018-0193-4

Abstract | Full Text

Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition

Chao Shi, Bei-Qing Pan, Feng Shi, Zhi-Hui Xie, Yan-Yi Jiang et al.

Oncogene 2018 37 :3260 - 3274; March 19, 2018; 10.1038/s41388-018-0217-0

Abstract | Full Text

AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma

Qiang Zuo, Jing Liu, Liping Huang, Yifei Qin, Teresa Hawley et al.

Oncogene 2018 37 :3275 - 3289; March 19, 2018; 10.1038/s41388-018-0205-4

Abstract | Full Text

Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism

Shao-Chiang Lai, Cody A. Phelps, Aleena M. Short, Sucharita M. Dutta & David Mu

Oncogene 2018 37 :3290 - 3300; March 19, 2018; 10.1038/s41388-018-0174-7

Abstract | Full Text

ß-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy

Concetta Saponaro, Sara Sergio, Antonio Coluccia, Maria De Luca, Giuseppe La Regina et al.

Oncogene 2018 37 :3301 - 3316; March 19, 2018; 10.1038/s41388-018-0170-y

Abstract | Full Text

Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation

Ki-Chun Yoo, Yongjoon Suh, Yoojeong An, Hae-June Lee, Ye Ji Jeong et al.

Oncogene 2018 37 :3317 - 3328; March 21, 2018; 10.1038/s41388-018-0199-y

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature